NCT01829893View on ClinicalTrials.gov

PK Comparison of GL2701 With Finasteride and Tamsulosin in Combination

PHASE1CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions

Benign Prostatic Hyperplasia (BPH)

Interventions

DRUG

In combination of 0.2mg finasteride and 5mg tamsulosin

oral medication with 240 mL water

DRUG

GL2701 capsule

oral medication with 240 mL water

Trial Locations (1)

136-705

Clinical trial center of Anam Hospital, Seoul

Sponsors

Collaborators (1)

GL Pharm Tech Corporation

All Listed Sponsors

collaborator

GL Pharm Tech Corporation

INDUSTRY

lead

Korea University Anam Hospital

OTHER

NCT01829893 - PK Comparison of GL2701 With Finasteride and Tamsulosin in Combination | Biotech Hunter | Biotech Hunter